Compare Novartis AG (NVS) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Verizon Communications Inc — how do they compare? Novartis AG trades at $153.53 (market cap $298.18B), while Verizon Communications Inc trades at $47.18 (market cap $195.40B). The key difference: Novartis AG is the larger of the two by market cap, and Verizon Communications Inc pays the higher dividend (6.02%). Which is the better fit depends on your goals.
| NVS | VZ | |
|---|---|---|
Market Cap | $298.18B | $195.40B |
Sector | Health | Media |
52-Week High | $168.62 | $51.38 |
52-Week Low | $119.31 | $38.40 |
Enterprise Value | $339.50B | $382.11B |
Dividend Yield | 3.02% | 6.02% |
Volume | — | 22,584,735 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
